Feedback / Questions
Zunveyl (benzgalantamine) - Alpha Cognition
https://www.businesswire.com/news/home/20250212688224/en/Alpha-Cognition-Secures-Additional-U.S.-Patent-for-ZUNVEYL-benzgalantamine-in-the-Treatment-of-Mild-to-Moderate-Alzheimer%E2%80%99s-disease
Feb 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next